Lifehealthcare Group Ltd is in takeover talks

The Lifehealthcare Group Ltd (ASX: LHC) share price won’t be going anywhere during trade on Monday after the healthcare solutions company placed its shares into a trading halt.

Why are its shares in a trading halt?

According to the release, management has requested the trading halt pending an announcement regarding a proposed acquisition of the company.

No further details were provided in the release but the AFR is reporting that Australia’s largest private equity firm, Pacific Equity Partners, is believed to be interested in taking over the company just four years after it listed on the Australian share market.

LifeHealthcare, which was previously owned by private equity group Crescent Capital Partners, was listed on the ASX at $2.01 per share in December 2013. On Friday its shares closed the week at $2.57.

What now for LifeHealthcare?

No takeover details have been provided, but I suspect a price north of $3.20 would be required to take the company private again. This equates to a premium of approximately 25% from the last close price.

Shareholders won’t have to wait long to find out for sure what is happening. According to the release, the company expects to reveal all in an announcement no later than Wednesday of this week.

Until then I think that investors ought to take a look at some of the other top shares available to them in the healthcare sector.

These include the likes of private hospital operator Ramsay Health Care Limited (ASX: RHC) and fast-growing medical imagining company Pro Medicus Limited (ASX: PME).

I think both of these companies have a long runway for growth which makes them well worth considering as a buy and hold investment today. Especially considering the favourable tailwinds the healthcare sector continues to experience from ageing populations around the world.

Alternatively, these growth shares could be even better options for investors.

Top 3 ASX Blue Chips To Buy In 2018

For many, blue chip stocks mean stability, profitability and regular dividends, often fully franked..

But knowing which blue chips to buy, and when, can be fraught with danger.

The Motley Fool’s in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool’s Top 3 Blue Chip Stocks for 2018."

Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.

The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand – and how quickly the share prices of these companies moves – we may be forced to remove this report.

Click here to claim your free report.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended PRO Medicus Ltd. The Motley Fool Australia has recommended Ramsay Health Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.